Displaying 201 - 210 of 293
Jacob Tourigny
Updated:
Jacob Tourigny was a lively 11-year-old boy with a passion for downhill skiing. In December 2018, he decided to put together a team to compete in a ski competition to support pediatric cancer research. Unfortunately, in February 2019, while ski season was in full swing, Jacob…
Precision medicine, chemotherapy alternatives, and zebrafish genes
Updated:
Canadian researchers exploring precision medicine with immunotherapy have received a total of $600,000 from the Leukemia and Lymphoma Society of Canada (LLSC) for pediatric blood cancer research innovation.
You’re not alone even if…you’re a young person living with cancer
Updated:
Canadian snowboarder and Olympic athlete Max Parrot had to put his life and career on hold when he was diagnosed with Hodgkin lymphoma. Now, he’s sharing his story to help other young people living with blood cancer
August Match Challenge
Updated:
This month, we are embarking on an exciting journey to magnify the impact of your generosity: Medicum Patient Assistance Program will match your donation, doubling its value, up to $25,000!
Insights from BioCanRX Summit for Cancer Immunotherapy 2023
Updated:
I just got back from the 2023 BioCanRX Summit4ci that was held in Ottawa October 1-4 and I want to share a few of the amazing highlights that have come out of the conference this year.
Cutaneous T-cell Lymphoma
Updated:
Learn more about cutaneous T-cell lymphoma and the resources we have available.
Moose Knuckles and Crowe BGK match opportunity!
Updated:
Canadian outerwear brand Moose Knuckles and financial services provider Crowe BGK have teamed up for a special offer to LLSC supporters...
Expanding access to CAR T-cell therapy across Canada
Updated:
One of the most exciting developments in the treatment of blood cancer is CAR T-cell therapy, a type of treatment that harnesses the power of the immune system.
Supporting the blood cancer community during the COVID-19 pandemic
Updated:
As we transition to our post-pandemic lives, COVID-19 continues to be a challenge for the blood cancer community, creating anxiety and isolation.